Loading company…
New York-based OneThree Biotech develops biotherapeutics and agricultural solutions using synthetic biology.
Founded in 2018 and based in New York, US, OneThree Biotech develops biotherapeutics and agricultural solutions that use synthetic biology to address chronic disease and crop resilience. Its clients include pharmaceutical companies, research institutions and agricultural enterprises in North America, Europe and Asia. Revenue comes from partnerships and B2B agreements, which may include milestone payments and revenue-sharing. The company raised USD 2.5 mn in Seed funding led by Meridian Street Capital and Primary Venture Partners in March 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in